<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2958485-A1" country="EP" doc-number="2958485" kind="A1" date="20151230" family-id="47832917" file-reference-id="308372" date-produced="20180822" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="160453699" ucid="EP-2958485-A1"><document-id><country>EP</country><doc-number>2958485</doc-number><kind>A1</kind><date>20151230</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-14705204-A" is-representative="NO"><document-id mxw-id="PAPP193870366" load-source="docdb" format="epo"><country>EP</country><doc-number>14705204</doc-number><kind>A</kind><date>20140219</date><lang>EN</lang></document-id><document-id mxw-id="PAPP193870367" load-source="patent-office" format="original"><country>EP</country><doc-number>14705204.7</doc-number><date>20140219</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC162033161" ucid="EP-13156366-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>13156366</doc-number><kind>A</kind><date>20130222</date></document-id></priority-claim><priority-claim mxw-id="PPC162034414" ucid="EP-14705204-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>14705204</doc-number><kind>A</kind><date>20140219</date></document-id></priority-claim><priority-claim mxw-id="PPC162029062" ucid="EP-2014053251-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>2014053251</doc-number><kind>W</kind><date>20140219</date></document-id></priority-claim><priority-claim mxw-id="PPC162034642" ucid="US-201361767862-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201361767862</doc-number><kind>P</kind><date>20130222</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-1988520296" load-source="docdb">A61B   5/024       20060101ALI20140910BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1988520722" load-source="docdb">A61B   5/1455      20060101ALI20140910BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1988527312" load-source="docdb">A61B   5/00        20060101AFI20140910BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1641018269" load-source="docdb" scheme="CPC">G06F  19/00        20130101 LI20180517BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987764821" load-source="docdb" scheme="CPC">A61B   5/0071      20130101 LI20140901BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987768695" load-source="docdb" scheme="CPC">A61B   5/6824      20130101 LI20140512BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987769408" load-source="docdb" scheme="CPC">A61B   5/02416     20130101 LI20130702BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987775276" load-source="docdb" scheme="CPC">A61B2562/164       20130101 LA20130702BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987777161" load-source="docdb" scheme="CPC">A61B   5/6814      20130101 LI20130702BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987786057" load-source="docdb" scheme="CPC">A61B   5/0059      20130101 FI20140828BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987786138" load-source="docdb" scheme="CPC">A61B2562/0233      20130101 LA20130702BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987786215" load-source="docdb" scheme="CPC">A61B   5/6833      20130101 LI20130703BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1987790844" load-source="docdb" scheme="CPC">A61B   5/14556     20130101 LI20130702BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT165552563" lang="DE" load-source="patent-office">MARKER MIT EINEM LICHTEMISSIONSBEREICH ZUR VERWENDUNG BEI DER BESTIMMUNG VON VITALZEICHENINFORMATIONEN</invention-title><invention-title mxw-id="PT165552564" lang="EN" load-source="patent-office">MARKER WITH LIGHT EMITTING AREA FOR USE IN DETERMINING VITAL SIGN INFORMATION</invention-title><invention-title mxw-id="PT165552565" lang="FR" load-source="patent-office">MARQUEUR DOTÉ D'UNE SURFACE D'ÉMISSION DE LUMIÈRE ET DESTINÉ À ÊTRE UTILISÉ DANS LA DÉTERMINATION D'INFORMATIONS SUR LES SIGNES VITAUX</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR1103321319" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>KONINKL PHILIPS NV</last-name><address><country>NL</country></address></addressbook></applicant><applicant mxw-id="PPAR1103320987" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>KONINKLIJKE PHILIPS N.V.</last-name></addressbook></applicant><applicant mxw-id="PPAR1101641412" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Koninklijke Philips N.V.</last-name><iid>101391185</iid><address><street>High Tech Campus 5</street><city>5656 AE Eindhoven</city><country>NL</country></address></addressbook></applicant><applicant mxw-id="PPAR1103337535" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>PHILIPS GMBH</last-name><address><country>DE</country></address></addressbook></applicant><applicant mxw-id="PPAR1103332217" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>PHILIPS GMBH</last-name></addressbook></applicant><applicant mxw-id="PPAR1101642552" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>Philips GmbH</last-name><iid>101482846</iid><address><street>Lübeckertordamm 5</street><city>20099 Hamburg</city><country>DE</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR1103324364" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DUBIELCZYK ALEXANDER</last-name><address><country>NL</country></address></addressbook></inventor><inventor mxw-id="PPAR1103326338" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DUBIELCZYK, ALEXANDER</last-name></addressbook></inventor><inventor mxw-id="PPAR1101651006" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>DUBIELCZYK, ALEXANDER</last-name><address><street>High Tech Campus 5</street><city>NL-5656AE Eindhoven</city><country>NL</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR1101648762" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Ledeboer, Johannes Albertus</last-name><iid>101489278</iid><address><street>Philips International B.V. Intellectual Property &amp; Standards High Tech Campus 5</street><city>5656 AE Eindhoven</city><country>NL</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="EP-2014053251-W"><document-id><country>EP</country><doc-number>2014053251</doc-number><kind>W</kind><date>20140219</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2014128172-A1"><document-id><country>WO</country><doc-number>2014128172</doc-number><kind>A1</kind><date>20140828</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS660756933" load-source="docdb">AL</country><country mxw-id="DS660641791" load-source="docdb">AT</country><country mxw-id="DS660756939" load-source="docdb">BE</country><country mxw-id="DS660732644" load-source="docdb">BG</country><country mxw-id="DS660722411" load-source="docdb">CH</country><country mxw-id="DS660640440" load-source="docdb">CY</country><country mxw-id="DS660641792" load-source="docdb">CZ</country><country mxw-id="DS660756940" load-source="docdb">DE</country><country mxw-id="DS660640441" load-source="docdb">DK</country><country mxw-id="DS660640442" load-source="docdb">EE</country><country mxw-id="DS660645162" load-source="docdb">ES</country><country mxw-id="DS660732645" load-source="docdb">FI</country><country mxw-id="DS660732646" load-source="docdb">FR</country><country mxw-id="DS660756941" load-source="docdb">GB</country><country mxw-id="DS660640451" load-source="docdb">GR</country><country mxw-id="DS660756942" load-source="docdb">HR</country><country mxw-id="DS660641793" load-source="docdb">HU</country><country mxw-id="DS660722412" load-source="docdb">IE</country><country mxw-id="DS660640452" load-source="docdb">IS</country><country mxw-id="DS660732659" load-source="docdb">IT</country><country mxw-id="DS660640453" load-source="docdb">LI</country><country mxw-id="DS660723435" load-source="docdb">LT</country><country mxw-id="DS660641794" load-source="docdb">LU</country><country mxw-id="DS660723436" load-source="docdb">LV</country><country mxw-id="DS660723437" load-source="docdb">MC</country><country mxw-id="DS660794563" load-source="docdb">MK</country><country mxw-id="DS660794564" load-source="docdb">MT</country><country mxw-id="DS660645167" load-source="docdb">NL</country><country mxw-id="DS660732660" load-source="docdb">NO</country><country mxw-id="DS660794565" load-source="docdb">PL</country><country mxw-id="DS660722413" load-source="docdb">PT</country><country mxw-id="DS660645168" load-source="docdb">RO</country><country mxw-id="DS660722414" load-source="docdb">RS</country><country mxw-id="DS660794566" load-source="docdb">SE</country><country mxw-id="DS660756951" load-source="docdb">SI</country><country mxw-id="DS660732661" load-source="docdb">SK</country><country mxw-id="DS660794567" load-source="docdb">SM</country><country mxw-id="DS660640454" load-source="docdb">TR</country></ep-contracting-states><ep-extended-states><ep-extended-state-data><country>BA</country></ep-extended-state-data><ep-extended-state-data><country>ME</country></ep-extended-state-data></ep-extended-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA139078626" ref-ucid="WO-2014128172-A1" lang="EN" load-source="patent-office"><p num="0000">The present invention relates to a system for determining vital sign information (7) of a subject (100) and a marker (10, 10', 20, 30, 40, 60, 70, 80, 90) for use in determining vital sign information (7) of a subject (100). An embodiment of a marker comprises a marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) for emitting light towards a skin (104) of the subject (100) for determining vital sign information (7) from the reflected light, and attachment means (23, 43, 73) for attaching the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) to the subject (100). An embodiment of a system further comprises a detection unit (2, 52) for detecting radiation emitted by the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), and an analysis unit (6) for determining the vital sign information (7) of the subject (100) from the detected radiation reflected from the skin (104) of the subject (100).</p></abstract><abstract mxw-id="PA139545181" ref-ucid="WO-2014128172-A1" lang="EN" source="national office" load-source="docdb"><p>The present invention relates to a system for determining vital sign information (7) of a subject (100) and a marker (10, 10', 20, 30, 40, 60, 70, 80, 90) for use in determining vital sign information (7) of a subject (100). An embodiment of a marker comprises a marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) for emitting light towards a skin (104) of the subject (100) for determining vital sign information (7) from the reflected light, and attachment means (23, 43, 73) for attaching the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) to the subject (100). An embodiment of a system further comprises a detection unit (2, 52) for detecting radiation emitted by the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), and an analysis unit (6) for determining the vital sign information (7) of the subject (100) from the detected radiation reflected from the skin (104) of the subject (100).</p></abstract><abstract mxw-id="PA139078627" ref-ucid="WO-2014128172-A1" lang="FR" load-source="patent-office"><p num="0000">La présente invention concerne un système pour déterminer des informations (7) sur les signes vitaux d'un sujet (100) et un marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) destiné à être utilisé pour déterminer des informations (7) sur les signes vitaux d'un sujet (100). Un mode de réalisation d'un marqueur comprend une surface de marqueur (11, 11', 22, 35, 36, 42, 48, 65, 72, 82, 92) destinée à émettre de la lumière en direction de la peau (104) du sujet (100) pour déterminer des informations (7) sur les signes vitaux à partir de la lumière réfléchie, et des moyens de fixation (23, 43, 73) pour fixer le marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) sur le sujet (100). Un mode de réalisation d'un système comprend en outre une unité de détection (2, 52) destinée à détecter des rayonnements émis par le marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) vers la peau (104) du sujet (100) et réfléchis par la peau (104) du sujet (100), et une unité d'analyse (6) destinée à déterminer des informations (7) sur les signes vitaux du sujet (100) à partir des rayonnements détectés réfléchis par la peau (104) du sujet (100).</p></abstract><abstract mxw-id="PA139545182" ref-ucid="WO-2014128172-A1" lang="FR" source="national office" load-source="docdb"><p>La présente invention concerne un système pour déterminer des informations (7) sur les signes vitaux d'un sujet (100) et un marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) destiné à être utilisé pour déterminer des informations (7) sur les signes vitaux d'un sujet (100). Un mode de réalisation d'un marqueur comprend une surface de marqueur (11, 11', 22, 35, 36, 42, 48, 65, 72, 82, 92) destinée à émettre de la lumière en direction de la peau (104) du sujet (100) pour déterminer des informations (7) sur les signes vitaux à partir de la lumière réfléchie, et des moyens de fixation (23, 43, 73) pour fixer le marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) sur le sujet (100). Un mode de réalisation d'un système comprend en outre une unité de détection (2, 52) destinée à détecter des rayonnements émis par le marqueur (10, 10', 20, 30, 40, 60, 70, 80, 90) vers la peau (104) du sujet (100) et réfléchis par la peau (104) du sujet (100), et une unité d'analyse (6) destinée à déterminer des informations (7) sur les signes vitaux du sujet (100) à partir des rayonnements détectés réfléchis par la peau (104) du sujet (100).</p></abstract><description mxw-id="PDES78477630" ref-ucid="WO-2014128172-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="3"/>--><p id="p0001" num="0001"> Marker with light emitting area for use in determining vital sign information </p><p id="p0002" num="0002">FIELD OF THE INVENTION </p><p id="p0003" num="0003"> The present invention relates to a marker for use in determining vital sign information of a subject. Further, the present invention relates to optical measurement approaches which can be used for remotely determining vital signs of an observed subject. In this context, optical measurement may refer to photo-plethysmography (PPG) and, more specifically, to pulse oximetry. </p><p id="p0004" num="0004">BACKGROUND OF THE INVENTION </p><p id="p0005" num="0005"> Vital signs of a person, for example the heart rate (HR), the respiration rate (RR) or the blood oxygen saturation, serve as indicators of the current state of a person and as powerful predictors of serious medical events. For this reason, vital signs are extensively monitored in inpatient and outpatient care settings, at home or in further health, leisure and fitness settings. </p><p id="p0006" num="0006"> One way of measuring vital signs is plethysmography. Plethysmography generally refers to the measurement of volume changes of an organ or a body part and in particular to the detection of volume changes due to a cardio -vascular pulse wave traveling through the body of a subject with every heart beat. </p><p id="p0007" num="0007"> Photoplethysmography (PPG) is an optical measurement technique that evaluates a time- variant change of light reflectance or transmission of an area or volume of interest. PPG is based on the principle that blood absorbs light more than surrounding tissue, so variations in blood volume with every heart beat affect transmission or reflectance correspondingly. Besides information about the heart rate, a PPG waveform can comprise information attributable to further physiological phenomena such as the respiration. By evaluating the transmissivity and/or reflectivity at different wavelengths (typically red and infrared), the blood oxygen saturation can be determined. </p><p id="p0008" num="0008"> Conventional pulse oximeters for measuring the heart rate and the oxygen saturation of a subject are attached to the skin of the subject, for instance to a finger tip, earlobe or forehead. Therefore, they are referred to as 'contact' PPG devices. A typical pulse oximeter comprises a red LED and an infrared LED as light sources and one photodiode for 
<!-- EPO <DP n="4"/>-->
 detecting light that has been transmitted through patient tissue. Commercially available pulse oximeters quickly switch between measurements at a red and an infrared wavelength and thereby measure the transmissivity of the same area or volume of tissue at two different wavelengths. This is referred to as time-division-multiplexing. The transmissivity over time at each wavelength gives the PPG waveforms for red and infrared wavelengths. Although contact PPG is regarded as a basically non- invasive technique, contact PPG measurement is often experienced as being unpleasant, since the pulse oximeter is directly attached to the subject and any cables limit the freedom to move. </p><p id="p0009" num="0009"> Recently, non-contact, remote PPG devices for unobtrusive measurements have been introduced. Remote PPG utilizes light sources or, in general radiation sources, disposed remotely from the subject of interest. Similarly, also a detector, e.g., a camera or a photo detector, can be disposed remotely from the subject of interest. Therefore, remote photoplethysmographic systems and devices are considered unobtrusive and well suited for medical as well as non-medical everyday applications. </p><p id="p0010" num="0010"> Verkruysse et al, "Remote plethysmographic imaging using ambient light",</p><p id="p0011" num="0011">Optics Express, 16(26), 22 December 2008, pp. 21434-21445 demonstrates that </p><p id="p0012" num="0012">photoplethysmographic signals can be measured remotely using ambient light and a conventional consumer level video camera. </p><p id="p0013" num="0013"> Camera based, contactless physiological measurements require enough light of appropriate wavelengths to extract the desired vital sign information. This can be achieved by ensuring, that the ambient illumination is set up accordingly. During sleep time, however, it can be a big discomfort for patients or other monitored subjects, if the light has to be turned on during a measurement. Furthermore, it is important that the optical spectrum of the illumination meets the requirements. For example, it is important for measuring the oxygen saturation of blood to have light of defined wavelengths, typically red and infrared. </p><p id="p0014" num="0014">SUMMARY OF THE INVENTION </p><p id="p0015" num="0015"> It is an object of the present invention to enable contactless vital sign measurements in dark rooms, for example at night, or in cases where the optical spectrum of the ambient illumination does not contain the wavelengths that are required for a certain measurement. </p><p id="p0016" num="0016"> In a first aspect of the present invention a marker for use in determining vital sign information of a subject is presented that comprises a marker area for emitting light 
<!-- EPO <DP n="5"/>-->
 towards a skin of the subject for determining vital sign information from the reflected light, and attachment means for attaching the marker to the subject. </p><p id="p0017" num="0017"> In a further aspect of the present invention a system for determining vital sign information of a subject is presented that comprises the marker as described above, a detection unit for detecting radiation emitted by the marker towards a skin of the subject and reflected from the skin of the subject, and an analysis unit for determining the vital sign information of the subject from the detected radiation reflected from the skin of the subject. </p><p id="p0018" num="0018"> In a further aspect of the present invention a device for use with the marker as described above is presented that comprises a detection unit for detecting radiation emitted by the marker towards a skin of the subject and reflected from the skin of the subject, and an analysis unit for determining the vital sign information of the subject from the detected radiation reflected from the skin of the subject. </p><p id="p0019" num="0019"> In a further aspect of the present invention a method for determining vital sign information of a subject is presented that comprises the steps of applying the marker as described above to the subject, detecting radiation emitted by the marker towards a skin of the subject and reflected from the skin of the subject, and determining the vital sign information of the subject from the detected radiation reflected from the skin of the subject. </p><p id="p0020" num="0020"> In a further aspect of the present invention a computer program is presented that comprises program code means for, when carried out on a computer, causing the computer to carry out the steps of detecting radiation emitted by a marker, applied to a subject, towards a skin of the subject and reflected from the skin of the subject, and determining the vital sign information of the subject from the detected radiation reflected from the skin of the subject. </p><p id="p0021" num="0021"> Preferred embodiments of the invention are defined in the dependent claims. It shall be understood that the claimed system, device, method and computer program have similar and/or identical preferred embodiments as the claimed marker and as defined in the dependent claims. </p><p id="p0022" num="0022"> The inventors have found that it is advantageous to selectively illuminate a region of interest of a skin of a subject for whom vital sign information is to be determined. In particular during the night this enables unobtrusive vital sign measurements. Instead of broadly illuminating an entire scenery, it is sufficient to only illuminate the region of interest. According to the invention, this is achieved by a marker comprising a marker area for emitting light towards a skin of the subject. The marker further comprises attachment means for attaching the marker to the subject. Hence, the marker is directly applied to the region of 
<!-- EPO <DP n="6"/>-->
 interest and emits light towards the skin of the subject directly where it is needed. The light emitting marker can be applied to clothing, a blanket, bed sheet or any item in proximity to the subject. Advantageously, the marker is directly applied to the skin of the skin of the subject. Since the light emitting marker is directly applied to the skin of the subject, the correct region of interest of the skin tissue is illuminated also if the patient moves. </p><p id="p0023" num="0023"> The marker emits light towards the skin of the subject. Some of the light penetrates the skin of the subject, in particular the upper layers of the skin tissue, and is reflected from inside the tissue. The reflected light has a time-variant intensity due to the time-variant absorption and/or transmission of light within the tissue. This time- variant intensity is analyzed to the determine the vital sign information of the observed subject. The absorption and/or transmission varies because of volume changes of blood vessels due to the cardio-vascular pulse wave traveling through the body of a subject with every heart beat. </p><p id="p0024" num="0024"> The interaction of light with biological tissue is complex and includes the optical processes of (multiple) scattering, backscattering, absorption, transmission and (diffuse) reflection. The term "reflect" as used in this context is not to be construed as limited to specular reflection but comprises the afore-mentioned types of interaction of light with tissue and any combinations thereof. </p><p id="p0025" num="0025"> The term 'vital sign' as used in the context of the present invention refers to a physiological parameter of a subject and derivative parameters. In particular, the term "vital sign" comprises heart rate (HR) (sometimes also called pulse rate), heart rate variability (pulse rate variability), pulsatility strength, perfusion, perfusion indicator, perfusion variability, Traube Hering Mayer waves, respiratory rate (RR), body temperature, blood pressure, a concentration of a substance in blood and/or tissue, such as an oxygen saturation or a glucose level. </p><p id="p0026" num="0026"> The term 'vital sign information' as used in the context of the present invention comprises the one or more measured vital signs as defined above. Furthermore, the term 'vital sign information' comprises data referring to a physiological parameter, corresponding waveform traces or data referring to a physiological parameter of a time that can serve for subsequent analysis. </p><p id="p0027" num="0027"> The term 'area' as used in the context of the present invention also comprises a plurality of sub-areas that are not necessarily connected to each other. </p><p id="p0028" num="0028"> According to a preferred embodiment, the marker area comprises fluorescent pigments and/or luminescent pigments for emitting light towards the skin of the subject. Advantageously, the marker area for emitting light towards a skin of the subject comprises a 
<!-- EPO <DP n="7"/>-->
 substance that illuminates the measurement site by luminescence, thus in particular by chemiluminescence due to a chemical reaction or alternatively by phosphorescence. </p><p id="p0029" num="0029"> Alternatively, the marker area for emitting light towards a skin of the subject comprises a substance that converts wavelengths from incident ambient light to a different wavelength by fluorescence. Fluorescent pigments convert light at a first wavelength to light at a second wavelength. Advantageously, said first wavelength is a non- visible wavelength. Using fluorescence, it is possible to illuminate the measurement site with non- visible ambient light, for example ultra-violet or infrared light without disturbing the patient during the night. Optionally fluorescent and luminescent pigments are combined in the same marker in the same or separate marker areas. </p><p id="p0030" num="0030"> The conversion of wavelengths by fluorescence also helps in vital sign measurements during the daytime when the ambient light spectrum does not contain wavelengths that are required for the measurement. For example, normal gas-discharge lamps often do not contain enough infrared light to do a measurement of blood oxygen saturation. Fluorescent pigments can convert energy from arbitrary available wavelengths to the specific wavelengths needed for the measurement. </p><p id="p0031" num="0031"> As used herein, the term "wavelength" also refers to a band of wavelengths or a wavelength portion. It is to be understood as a spectral range having a limited spectral width. For example, for an optical filter the term "wavelength" refers to a passband of the filter. Hence, the term "wavelength" is not limited to a single wavelength but is also used for a wavelength range, for example of some nanometers or some tens of nanometers, around a center wavelength. Moreover, the term "wavelength" in the context of filter can also refer to multiple discontinuous spectral ranges of one and the same filter element. </p><p id="p0032" num="0032"> According to a further embodiment of the present invention, the marker comprises a first marker area for emitting light at a first wavelength and/or a second marker area for emitting light at a second wavelength. The first marker area and the second marker area can be separate, directly adjacent, overlapping or can also coincide. The use of at least partially separate first marker area and second marker area is advantageous since the first marker and the second marker area thereby define spatially separate areas that can be evaluated for determining vital sign information. Each marker area is configured to emit light at a different wavelength so that the concentration of a substance can be determined based on a comparison of the light reflected from the tissue at the two different wavelengths. The use of this kind of marker has the advantage that no specific additional filtering at a detection unit such as a camera is needed. The different areas of different wavelengths can be separated in 
<!-- EPO <DP n="8"/>-->
 the detection unit, an image processing unit or an analysis unit by spatial decomposition. Thus, a single detection unit can acquire all the required information which is beneficial for a low system cost. </p><p id="p0033" num="0033"> Optionally, the marker comprises further marker areas that are configured to emit light at further wavelengths. The wavelengths of interest also comprise non- visible wavelengths of electromagnetic radiation, including infrared and ultra-violet wavelengths. </p><p id="p0034" num="0034"> In yet another embodiment, the marker further comprises a transmission area for transmitting light. It is advantageous to not only detect light that is reflected from the tissue externally surrounding the marker but also from regions that are enclosed by the marker. A transmission area can be an opening in the marker. Alternatively, a transmission area is a marker area for transmitting light at a desired wavelength or simply transparent for example over the entire visible, infrared and ultraviolet spectrum. A transmission area is also referred to as a 'window' or Optical window'. A transmission area can optionally comprise a optical filter such as an optical filter plate that ensures that only light of the desired wavelength is transmitted. The types of filter plate include absorption filters as well as dielectric filters. </p><p id="p0035" num="0035"> According to a variation of this embodiment, the marker comprises a first transmission area for transmitting light at a first wavelength and/or a second transmission area for transmitting light at a second wavelength. The first transmission area and the second transmission area thereby define spatially separate areas for determining the vital sign information. Each transmission area is configured to transmit light at a different wavelength, so that the concentration of the substance can be determined based on the comparison of light at the two different wavelengths with the advantages discussed above. </p><p id="p0036" num="0036"> In a further embodiment, the marker comprises an opaque marker area. </p><p id="p0037" num="0037">Advantageously, an opaque marker area ensures that light from the marker area for emitting light towards a skin of the subject is only or at least predominantly emitted towards a skin of the subject. The opaque marker area can be understood as a light shield on top of the light emitting marker area or a portion of the marker that at least blocks light at the wavelength or the wavelengths emitted by the light emitting marker area or areas. Light directly coming from the light emitting marker area can be much stronger than the light reflected from the skin of the subject. Thus, in the detection process, problems with a dynamic range of a detector or leakage effects from one detector pixel into its neighbors can occur, if no opaque marker area is used. Furthermore, an opaque marker area can be used to separate marker areas for emission or transmission of light at different wavelengths. 
<!-- EPO <DP n="9"/>-->
 In a further embodiment, the marker comprises a reference area of predefined reflection characteristic. This reference area can be used for calibration since the reflection characteristic for a predetermined range of wavelengths is known. In particular when an optional light source for illuminating the marker and an optional control unit for controlling said light source are used, the reference area can serve for adjusting a sensitivity of a detector and/or for adjusting a power and/or spectrum of a light source. The marker can also comprise more than one reference area, wherein each reference area has a different reflection characteristic. For example, a red reference area is used to determine the optical power in the red spectral region, whereas a reference area that reflects light in the infrared is used to determine the optical power in the infrared spectral region. Based on these measurements, the sensitivity of the detection unit can be adjusted. Alternatively, the measurement time is adjusted to achieve a sufficiently good signal-to-noise ratio. </p><p id="p0038" num="0038"> Moreover, the reference area can be used to determine any temporal or spectral disturbances of the ambient light and/or an artificial light source, for example, slow changes during the day or systematic influences such as 50/60 Hertz flicker or a pulse-width modulation of the light source. The measured intensity from the first and/or second marker area can be corrected for such disturbances. </p><p id="p0039" num="0039"> In yet another embodiment, the marker further comprises a graphical pattern. Preferably, the graphical pattern has a high image contrast, for example, a black and white pattern. Alternatively, the graphical pattern comprises different colors that can be clearly distinguished. Favorably, the graphical pattern is optimized to be machine-readable such as a barcode, a matrix barcode, alphanumerical characters, a QR-code or the like. For detection by image processing methods, it is easier to detect a specific graphical pattern in an observed scene than analyzing unspecified image features. Optionally, the graphical pattern is a machine-readable code that stores information, such as a patient identifier for assigning the measured vital sign information to a patient or a body part of the patient. The encoded information can further comprise configuration data for configuring a system for determining vital sign information for example, a required sensitivity or information about the vital sign information to be measured. Alternatively, the graphical pattern provides information about the location of a region of interest for determining vital sign information, for example a location relative to the location of the marker. The arrangement of the marker area as well as the size and/or shape of the marker can also be seen as a graphical pattern. Furthermore, a graphical pattern can be made fluorescent or luminescent as well, to make it readable in a dark environment. 
<!-- EPO <DP n="10"/>-->
 In a further embodiment of the marker according to the present invention, the emission of light is activated by chemical reaction. The emission of light by luminescence due to a chemical reaction is also referred to as chemiluminescence. This can be for example achieved by lamination. In this example the marker comprises separate parts or layers that are produced and diverted independently and then attached or glued to each other right before use. Each of the separate parts comprises one of the substances that then react with each other to emit light by luminescence. As soon as the substances get in touch physically, the reaction starts. </p><p id="p0040" num="0040"> In a further example, at least one of the substances is a component of an ink that is printed on the marker as soon as the light emission from the marker is needed. The marker comprises a carrier material that contains the second component needed for the luminescence reaction. The printing approach also works for two different inks containing each of the substances for the chemical reaction which are then mixed in the printing process. </p><p id="p0041" num="0041"> In a further example, the marker is a first basic component while the second component is comprised in a fluid. The reaction starts as soon as the fluid is brought to the surface of the marker, for example by spraying or brushing the fluid onto it. </p><p id="p0042" num="0042"> In a preferred embodiment of the invention, the marker comprises a carrier layer for providing mechanical stability of the marker, a light emission layer comprising fluorescent and/or luminescent pigments for emitting light towards the skin of the subject and an attachment layer comprising an adhesive for attaching the marker to the subject. In general, the carrier layer can be thought of as an element that provides mechanical stability of the marker. For example, the carrier element can be made from a material of a group of materials comprising paper, textile, rubber or further materials, in particular materials used for patches in medical applications. Advantageously, the adhesive is a bio-compatible adhesive in particular for medical applications. </p><p id="p0043" num="0043"> In an alternative embodiment, the light emitting marker is directly applied to the skin of the subject. For example, a type of paint, ink or dye or generally a fluid or liquid that comprises a light emitting substance is directly applied to the skin of the subject to form the marker area for emitting light towards the skin of the subject, such that no further mechanical stabilization is needed. The skin of the subject provides the required mechanical stabilization. In this context, attachment means refers to the carrier fluid that comprises the light emitting substance. </p><p id="p0044" num="0044"> In an aspect of the present invention, an applicator for applying the marker as described above to a skin of a subject is presented. The applicator is used to apply the light 
<!-- EPO <DP n="11"/>-->
 emitting marker directly to the skin of the subject. For example, the applicator is a type of pen or highlighter that comprises the carrier fluid and the light emitting substance. </p><p id="p0045" num="0045">Alternatively, the applicator is a stamp for stamping or rubber printing the substance for the marker area for emitting light towards the skin of the subject directly on the skin of the subject. Optionally, light emission is activated by a chemical reaction when the marker is applied to the skin of the subject. Alternatively, two inks with components for a luminescent reaction are brought into contact on the skin of the subject by rubber printing them on top of each other. </p><p id="p0046" num="0046"> The context of the present invention is a system for determining vital sign information of a subject comprising a marker as described above, a detection unit and an analysis unit. </p><p id="p0047" num="0047"> As used herein, the term "detection unit" refers to a device for detecting electromagnetic radiation. It is configured to detect radiation emitted by the marker towards a skin of the subject and reflected from the skin of the subject. Hence, light that has penetrated into the skin tissue of the subject and is reflected therefrom can be detected. This reflected radiation comprises the vital sign information of interest. In a preferred embodiment, the detection unit is a camera with an image sensor, such as a CCD or CMOS image sensor that comprises an array of light-sensitive pixels. The output of the detection unit is referred to as radiation data. For example, the radiation data is a series of images over time, thus a video stream. The camera can be a monochrome or color camera. </p><p id="p0048" num="0048"> The received radiation, in particular the radiation received from the surroundings of the marker area for emitting light towards a skin of the subject and also from any optional transmission area comprises light that has penetrated into the skin and is reflected from inside the tissue. This received radiation has a time- variant intensity due to the time-variant absorption and/or transmission of light within the tissue. </p><p id="p0049" num="0049"> Optionally, the system further comprises a light source. This light source can be at a wavelength that is evaluated in determining the vital sign information of the subject and/or at a wavelength, in particular a non- visible wavelength, which is then converted to the wavelength desired for measurement by fluorescent pigments of the marker area for emitting light towards the skin of the subject. Further optionally, the system comprises a control unit to control the light power such that the detection unit can be operated in its optimum operating point in particular such that, for example, noise or saturation effects do not disturb the measurement. 
<!-- EPO <DP n="12"/>-->
 The analysis unit is configured to determine the vital sign information of the subject from the detected radiation reflected from the skin of the subject. The analysis unit receives the radiation data from the detection unit. For determining the heart rate of the subject it is sufficient to evaluate the time- variant radiation received at a single wavelength. However, for determining a concentration of a substance, for example for determining a blood oxygen saturation or a glucose level, the analysis of radiation at different wavelengths is required. </p><p id="p0050" num="0050"> In yet another embodiment, the system further comprises an image processing unit for identifying the marker in the detected radiation. The image processing unit is an optional element that is located between the detection unit and the analysis unit. The image processing unit receives radiation data, for example a video stream, from the detection unit. The image processing unit comprises image processing means for identifying the marker in the received radiation data. For example, the marker has particular features that can be identified in an image of video stream. Analysis methods known from image processing and video analysis can be applied. The image processing unit can provide the analysis unit with processed radiation data that comprises information about the location of the marker in the radiation data. In particular in darkness, the radiation caused by the light emitting marker can easily be identified. For example, the image processing unit identifies a pixel or a group of pixels that represent portions of the image sensor that received light from the marker or reflected light from the surroundings of the marker. Optionally, the image processing unit is incorporated into the analysis unit. </p><p id="p0051" num="0051">BRIEF DESCRIPTION OF THE DRAWINGS </p><p id="p0052" num="0052"> These and other aspects of the invention will be apparent from and elucidated with reference to the embodiment(s) described hereinafter. In the following drawings </p><p id="p0053" num="0053"> Fig. 1 shows an exemplary embodiment of a system for determining vital sign information of a subject according to the present invention; </p><p id="p0054" num="0054"> Fig. 2a shows a side view of a first embodiment of a marker; </p><p id="p0055" num="0055"> Fig. 2b shows a top view of the first embodiment of the marker; Fig. 3a shows a top view of a second embodiment of a marker;</p><p id="p0056" num="0056">Fig. 3b shows a bottom view of the second embodiment of the marker; </p><p id="p0057" num="0057"> Fig. 4 shows a side view of a third embodiment of a marker; </p><p id="p0058" num="0058"> Fig. 5 shows the determination of vital sign information with the system according to the present invention; 
<!-- EPO <DP n="13"/>-->
 Fig. 6 shows a side view of a fourth embodiment of a marker; </p><p id="p0059" num="0059"> Fig. 7 shows a side view of a fifth embodiment of a marker; </p><p id="p0060" num="0060"> Fig. 8a shows a top view of a sixth embodiment of a marker; </p><p id="p0061" num="0061"> Fig. 8b shows a bottom view of the sixth embodiment of the marker; </p><p id="p0062" num="0062"> Fig. 9a shows a top view of a seventh embodiment of a marker;</p><p id="p0063" num="0063">Fig. 9b shows a bottom view of the seventh embodiment of the marker. </p><p id="p0064" num="0064">DETAILED DESCRIPTION OF THE INVENTION </p><p id="p0065" num="0065"> Fig. 1 shows an exemplary embodiment of a system 1 for determining vital sign information of a subject that comprises a marker 10 and a device 13 for use with said marker. The marker 10 comprises a marker area 11 for emitting light towards a skin of the subject. The light is emitted towards the skin of the subject for determining vital sign information from the reflected light. The device 13 for use with the marker 10 comprises a detection unit 2 and an analysis unit 6 as the basic components. In this example, the system for determining vital sign information of the subject is employed in a clinical setting, where the subject 100 lies in bed 103. </p><p id="p0066" num="0066"> The detection unit 2 is adapted to detect radiation emitted by the marker 10 towards a skin of the subject 100 and reflected from the skin of the subject 100. In other words, light is emitted by the marker 10 towards the skin of the subject, where at least a part of it is reflected. The reflected light is then detected by the detection unit 2. In this example, the detection unit 2 is connected to an optional image processing unit 4. The detection unit 2 provides radiation data 3 that represents the detected radiation to the image processing unit 4 in form of a video stream. The image processing unit 4 identifies the marker 10 in the radiation data 3. The image processing unit 4 in turn is connected to the analysis unit 6. The image processing unit 4 provides pre-processed radiation data 5 to the analysis unit 6. The pre-processed radiation data 5 in this example comprises information about which region of the images of the video stream in the radiation data 3 depict the marker 10 and the surroundings of the marker 10. The analysis unit 6 in turn determines the vital sign information 7 of the subject from a time- variant intensity from radiation received from the surroundings of the marker 10, i.e., that area of the skin where light that has been emitted by the marker towards the skin is reflected from. In this example with a single marker area, the vital sign information comprises a heart rate. </p><p id="p0067" num="0067"> The image processing unit 4 for identifying the marker 10 can also be incorporated into the analysis unit 6. Alternatively, the radiation data 3 is directly provided to 
<!-- EPO <DP n="14"/>-->
 the analysis unit 6. In that case, the marker 10 can be determined by manually selecting the marker 10 and the surrounding area in the images of the video stream. Alternatively, the subject 100 with the marker 10 has to be located in a predetermined position within the field of the detection unit 2 such that the marker 10 is located at a predetermined position. </p><p id="p0068" num="0068">However, an automated identification of the marker 10 in the radiation data 3 by the image processing unit 4 is preferred. </p><p id="p0069" num="0069"> In the shown example, a marker 10 is directly applied to the bare skin of the forehead 101 of the subject 100. An alternative marker 10' is located at the left forearm 102 of the subject 100. The size and shape of the marker 10, 10' can be adapted depending on the anatomic location. </p><p id="p0070" num="0070"> The marker 10 on the forehead 101 of the subject 100 further comprises a transmission area 12 for transmitting light. Thus light reflected from the tissue of the subject in the transmission area 12 can also be detected by the detection unit 2 and evaluated by the analysis unit 6. </p><p id="p0071" num="0071"> In a system according to the prior art, the scenery has to be illuminated by a source of radiation, such as sunlight 7a or an artificial light source 7b. The radiation source 7a, 7b directly or indirectly emits radiation 8a, 8b towards the subject 100. </p><p id="p0072" num="0072"> With the system 1 according to the present invention, no such light sources 7a, 7b are needed anymore; at least the radiation sources do not have to contain the wavelengths that are required for certain vital sign measurements. For the case that the marker 10 comprises luminescent pigments for emitting light towards the skin of the subject, no ambient light sources are needed at all. For the case that the marker 10 comprises fluorescent pigments for emitting light towards the skin of the subject 100, the requirements regarding the spectrum of the ambient light can be relaxed. It is also possible to use an optional system light source 7c that emits radiation 8c towards the subject. Advantageously, the radiation 8c emitted by the system light source illuminates the measurement site with non- visible light in the ultra-violet or infrared spectral region. Thereby, the subject 100 is not disturbed, for example, during the night. Fluorescent pigments convert energy from the absorbed light 8c to the specific wavelength needed for the vital sign measurement. </p><p id="p0073" num="0073"> An optional control unit 9 is adapted to control the sensitivity of the detection unit 2 and/or to control the power of the optional system light source 7c. Because the dynamic range of a detector or image sensor that is used as a detection unit 2 is limited, shutters and/or electronic offsets may have to be adjusted according to the lighting situation in the observed scene. The system light source 7c can be part of a control loop for setting an 
<!-- EPO <DP n="15"/>-->
 optimal operating point of the image sensor and of the detection unit 2. Optimal in this context refers to an output signal without signal clipping, no saturation of individual detectors of the image sensors and a good signal-to-noise ratio at least for the detector area </p><p id="p0074" num="0074">corresponding to the marker 10, 10' and its surrounding. </p><p id="p0075" num="0075"> Fig. 2 illustrates a marker 20 for use in determining vital sign information of a subject 100 according to the present invention. The marker 20 comprises a carrier layer 21 for providing mechanical stability to the marker 20, a light emission layer 22 for emitting light towards the skin 104 of the subject, and an attachment layer 23 comprising an adhesive for attaching the marker 20 to the skin 104 of the subject. The skin or skin tissue 104 of the subject comprises blood vessels 105. </p><p id="p0076" num="0076"> In a first example, the light emission layer 22 emits light 24 by luminescence from luminescent pigments comprised in the light emission layer 22. In this example, the carrier layer 21 is opaque, i.e., the carrier layer 21 does not transmit light at least in the emission spectrum of the luminescent pigments. </p><p id="p0077" num="0077"> Light 24 is emitted from the light emission layer 22 towards the skin 104 of the subject and penetrates into the skin tissue. Some of the light is absorbed, but also some of the light is reflected 25 within the tissue 104. Blood that pulsates through the blood vessels 105 in the tissue 104 affects the transmission and reflectance of the light with every heartbeat. Therefore, the portion 26 of the reflected light that exits the tissue 104 has a time- variant intensity that represents the cardio-vascular pulse wave traveling through the body of the subject with every heartbeat. Light 27 that is absorbed underneath the marker cannot be detected. </p><p id="p0078" num="0078"> Fig. 2b shows a top view of the marker 20 applied to the skin 104 of the subject. In this example, the portion 26 of the reflected light that exits the tissue 104 can be detected in the surrounding of the marker 20. </p><p id="p0079" num="0079"> In a second example of Fig. 2a, the light emission layer 22 comprises fluorescent pigments for emitting light towards the skin 104 of the subject. In this example, the light source 28 emits light at a first ultra-violet, non-visible wavelength towards the subject with the marker 20. The carrier layer 21 is transparent for this first wavelength. </p><p id="p0080" num="0080"> In a third example of Fig. 2a, the carrier layer 21 is omitted. Instead of using a separate light emission layer 22 and an attachment layer 23, these layers are replaced by an ink that is directly applied to the skin 104 of the subject 100. The ink comprises luminescent pigments for emitting light. Some of the light is emitted towards the skin of the subject. Thus the ink also serves for attaching the luminescent pigments to the skin of the subject. 
<!-- EPO <DP n="16"/>-->
 Attachment means in this context are the (chemical) components of the ink the keep the ink on the skin of the subject and thereby prevent the luminescent pigments form moving. </p><p id="p0081" num="0081"> Optionally, an additional layer of opaque ink is applied on top of the light emitting layer of ink to block the emission of light away from to skin of the subject at least in parts of the marker area. As in the previous example, the portion 26 of the reflected light that exits the tissue 104 can be detected in the surrounding of the marker 20. Known image processing techniques can be used to identify the surrounding of the marker. </p><p id="p0082" num="0082"> Fig. 3a shows a top view of a further embodiment of a marker according to the present invention. When applied to the skin of the subject, the depicted top surface faces towards the detection unit 2 and away from the skin of the subject. The marker 30 comprises a first graphical pattern 31 and a second graphical pattern 32. Optionally, the graphical patterns also comprise fluorescent and/or luminescent pigments. Thereby, the graphical patterns can also be detected in the darkness. </p><p id="p0083" num="0083"> The marker 30 further comprises a first transmission area 33 and a second transmission area 34 for transmitting light. </p><p id="p0084" num="0084"> Fig. 3b shows a bottom view of the marker of Fig. 3a, i.e., the side of the marker that faces towards the skin 104 of the subject 100. The marker 30 comprises a first marker area 35 for emitting light at a first wavelength and a second marker area 36 for emitting light at a second wavelength. When applied to the skin of the subject, light at the first wavelength is predominantly detected in the first transmission area 33 and light emitted at the second wavelength is predominantly detected in the second transmission area 34. The transmission areas 33, 34 are also referred to as windows or optical windows. In this example, the optical windows are surrounded by chemically active areas that illuminate the measurement site at the tissue below the marker 30 by luminescence when the marker 30 is applied to the skin 104 of the subject 100. </p><p id="p0085" num="0085"> Fig. 4 shows a similar embodiment of a marker 40 that comprises a first marker area 42 for emitting light at a first wavelength and a second marker area 48 for emitting light at a second wavelength. In this embodiment, the light emission layer comprising the first and second light emitting area 42, 48 is applied on top of a carrier layer 41 which is attached to the skin 104 of the subject by an adhesive layer 43. The carrier layer 41 in this example as well as the layer of adhesive 43 are transparent. </p><p id="p0086" num="0086"> The first marker area 42 emits light 44 towards the skin of the subject 104. Some of the light is reflected 45 inside the tissue. Light 46 at the first wavelength exits the skin tissue 104 through the optical window formed at the center of the first marker area and 
<!-- EPO <DP n="17"/>-->
 light 49 at the second wavelength exits the skin tissue 104 through the optical window formed at the center of the second marker area 48. Thus, light at two different wavelengths that carries photoplethysmographic information in its time-variant intensity exits the skin of the subject at two spatially separate areas. The central portion 47 of the marker 40 is opaque and does not transmit light. This improves the separation of the two marker areas 42,48. </p><p id="p0087" num="0087"> Fig. 5 illustrates the determination of vital sign information of the subject with the system 1 according to the present invention. Fig. 5 shows a detection unit 52 and the marker 40 from Fig. 4. </p><p id="p0088" num="0088"> The detection unit 52 comprises receiving optics 51, for example a receiver lens, and an array 55 of photodetectors or pixels that form an image sensor. Light 46 that is received from the optical window formed at the center of the first marker area 42 is imaged onto a first group or array of pixels 56. Correspondingly, light 49 received from the optical window at the center of the second marker area 48 is imaged onto a second group of pixels 57. Since the absorption of light in the tissue 104 is time-variant, the light intensity incident on the image sensor of the detection unit 22 is also time- variant. Since the absorption of light in the tissue 104 is also wavelength-dependent, the light intensity incident on the first group of pixels 56 and on the second group of pixels 57 is different. The time- variant intensity on the area of pixels 56 is depicted by a curve 58. The time- variant intensity incident on the group of pixels 57 is depicted by the curve 59. </p><p id="p0089" num="0089"> The pulse rate of the subject can be directly determined from the time-variant intensity in one of the curves 58 or 59. However, for determining the blood oxygen saturation by photoplethysmography, at least two wavelengths are required, as exemplarily explained below. </p><p id="p0090" num="0090"> Contact pulse oximeters typically transmit red (R) and infrared (IR) (or, more precisely, in some cases near infrared) light through a vascular tissue of the subject of interest. The respective light portions (R/IR) can be transmitted and detected in an alternating (fast-switching) manner. Given that the respective spectral portions are differently absorbed by oxygenated hemoglobin (Hb0<sub>2</sub>) and reduced hemoglobin (Hb), blood oxygen saturation eventually can be processed. An oxygen saturation (S0<sub>2</sub>) estimation algorithm can make use of a ratio of the signals related to the red and the infrared portion. Furthermore, the algorithm can consider a non-pulsatile signal component. Typically, the PPG signal comprises a DC component and a relatively small pulsatile AC component. Furthermore, S0<sub>2</sub> estimation generally involves an empirically derived calibration factor applied to the processed values. Typically, the calibration factor (or, calibration curve) is determined upon reference 
<!-- EPO <DP n="18"/>-->
 measurements involving invasive blood oxygen saturation measurements. A calibration factor is required since a PPG device basically detects a ratio of (spectral) signal portions which has to be transferred into a blood oxygen saturation value which typically involves a ratio of Hb0<sub>2</sub> and Hb. For instance, but not intended to limit the present disclosure, blood oxygen saturation estimation can be based on the following general equation: </p><p id="p0091" num="0091">HbQ<sub>2</sub> </p><p id="p0092" num="0092"> HbO + Hb ' whereas PPG devices merely mediately detect Hb0<sub>2</sub> and Hb from the spectral response at at least two wavelengths. </p><p id="p0093" num="0093"> Generally, the measured intensity curve 28, 29 as a characteristic signal is considered to contain a considerably constant (DC) portion and an alternating (AC) portion superimposing the DC portion. Applying signal processing measures, the AC portion can be extracted and, furthermore, compensated for disturbances. For instance, the AC portion of the characteristic signal can comprise a dominant frequency which can be highly indicative of the subject's 100 vascular activity, in particular the heart beat. Still, the characteristic signal, in particular the AC portion, can be indicative of further vital parameters. In this connection, the detection of arterial blood oxygen saturation is an important field of application. As indicated above, basically, arterial blood oxygen saturation-representative values can be computed taking into account the behavior of the AC portion of the characteristic signal at distinct spectral portions thereof. In other words, a degree of arterial blood oxygen saturation can be reflected in different radiation absorbance at blood vessels. Furthermore, one can make use of the fact that the difference in absorbance due to the grade of oxygenation also varies significantly across different spectral portions. Moreover, also the DC portion of the signal can be utilized for blood oxygen saturation detection. Typically, the DC component represents the overall light absorption of the tissue, venous blood, and non-pulsatile arterial blood. By contrast, the AC component may represent the pulsatile arterial blood's absorption. Consequently, the determination of arterial blood oxygen saturation (Sa0<sub>2</sub>) can be expressed as: </p><p id="p0094" num="0094">(2) 
<!-- EPO <DP n="19"/>-->
 where C is a calibration parameter. C may stand for a large variety of calibration parameters applicable to the AC/DC relationship and should therefore not be interpreted in the strict algebraic sense of equation (2). C may, for example, represent a fixed constant value, a set of fixed constants or an adjustable calibration parameter. By way of example, another exemplary Sa0<sub>2</sub> derivation model can be expressed as: </p><p id="p0095" num="0095">Sa0<sub>2</sub> = C<sub>l +</sub> C<sub>2</sub> - t<sup>C/</sup>J <sup>C)red</sup> , (3) </p><p id="p0096" num="0096"> (AC / DC) i.nfrared where Ci and C<sub>2</sub> can be considered calibration parameters of a linear approximation. In an exemplary embodiment, the signal calibration parameter determination can be directed to adjust or adapt the parameter Ci . Still, in the alternative, Sa0<sub>2</sub> derivation may also be based on value tables deposited in (or accessible by) the analysis unit 6. The value tables (or: data bases) may provide for a discrete representation of the relationship between detected PPG signals und the desired calibration parameter. Also in that case an adaptable calibration parameter may be applied to improve the accuracy of the vital parameter determination. </p><p id="p0097" num="0097"> It should be understood that the equations (2) and (3) are primarily presented for illustrative purposes. They should not be construed as limiting the scope of the present disclosure. In practice, the skilled person may determine and establish further appropriate Sa0<sub>2</sub> derivation models. Alternative wavelength combinations, for example green and red, can be used depending on the substance to be detected. While the measurement of Sa0<sub>2</sub> has been described in detail, this is to be understood as an example for the general concept of measuring the concentration of a substance in blood and/or tissue. </p><p id="p0098" num="0098"> Fig. 6 shows a modification of the marker 40 from Fig. 4. The second marker area is simply removed, such that the marker 60 is transparent in this area. A light source 61 emits light 62 at an infrared, non- visible wavelength onto the skin tissue 104 of the subject 100 with the marker 60. Some of the light penetrates 62 into the skin tissue, is reflected 63 and exits 64 the tissue 104 again. The light 64 that exits the tissue 104 is intensity-modulated by the pulsatile absorption variation. The first marker area 65 comprises fluorescent pigments that convert the energy from the light 62 emitted by the light source 61 to red light. Some of this red light is emitted towards the skin and penetrates 66 into the skin tissue, is reflected 67 and exits 68 the tissue 104 again. The light 68 that exits the tissue 104 at this first (red) wavelength and the light that exits the tissue 104 at the second (infrared) wavelength 64 can be used for determining the concentration of a substance in the tissue 104. Optionally, the 
<!-- EPO <DP n="20"/>-->
 carrier layer underneath the first marker area acts as a filter that blocks light at the </p><p id="p0099" num="0099">wavelength of the light source 61. </p><p id="p0100" num="0100"> Fig. 7 shows a further embodiment of a marker 70 according to the present invention. The marker again comprises a carrier layer 71, a light emission layer 72 and an attachment layer 73. The marker 70 is attached to the skin 104 of the subject 100. In this embodiment, the light emission layer 72 at least comprises luminescent pigments for emitting light at a first wavelength and luminescent pigments for emitting light at a second </p><p id="p0101" num="0101">wavelength. Alternatively, the light emission layer 72 is a broadband emitter. The marker 70 features reference areas 74a, 75a, 76a, and transmission areas 75b, 76b configured to transmit light at two different wavelengths, and a transparent marker area 74b. </p><p id="p0102" num="0102"> In this embodiment, the marker is a patch or band-aid that can be directly attached to the skin of the subject 100 thanks to the adhesive layer 73. Alternatively, the marker 70 itself does not comprise an adhesive but is fixed to the skin of the subject by alternative fixation means, for example by a bandage or tape that act as attachment means of the marker. </p><p id="p0103" num="0103"> In this embodiment, the carrier layer 71 is made from an opaque rubber- like material that does not transmit light. Therefore, the carrier element features openings or windows at the positions of the marker areas 74b, 75b, 76b. In each of the windows 74b, 75b, 76b an optical filter plate is placed wherein the optical filter plate in 75b is configured to transmit light at a first wavelength, the filter plate in 76b is configured to transmit light at a second wavelength. The optical window at 74b does not have a frequency-selective filter but is transparent so that the layer of luminescent pigments 72 can be seen by the detection unit as a reference or for calibration. Direct optical access to the light emitting layer is also advantageous to determine if the light emission still is sufficiently strong for the </p><p id="p0104" num="0104">measurement task. Optionally, the adhesive layer 73 can be removed underneath the optical windows, as exemplary shown under 76b, for better transmission characteristics. </p><p id="p0105" num="0105"> The reference areas 75a, 76a are reference areas for specific wavelengths. Preferentially, the color of the reference area corresponds to the transmission wavelength of the neighboring filter. For example, marker area 75b is configured to transmit green light and the reference area 75 a has green color so that it can serve as a reference, in particular as to how much green light is available in the radiation that is incident on the marker. In an embodiment, where fluorescence is used, such reference areas can be used to determine if the spectrum and intensity of the ambient light is sufficient for a measurement with ambient light or if an additional system light source should be activated. 
<!-- EPO <DP n="21"/>-->
 Fig. 8a shows a top view of a further exemplary embodiment of a marker 80 according to the present invention, Fig. 8b shows a bottom view of the same. Depending on the desired measurement it can be necessary to arrange the optical windows 85b, 86b as close as possible. As shown in Fig. 7, the optical windows 85b, 86b can be combined with optical filters that prevent wavelength crosstalk between the windows. To characterize ambient light effects this can also be combined with opaque reference areas 85a, 86a of different reflectance characteristics. If filters are used in the optical windows 85b, 86b, luminescent pigments for the required wavelength can be mixed in a common light emitting layer 82 and distributed on the entire bottom surface of the marker 80. </p><p id="p0106" num="0106"> In this embodiment, the maker comprises an opaque carrier layer 81. The light emitting layer 82 can also be seen from the top surface through transparent optical windows 84b. </p><p id="p0107" num="0107"> The marker 80 further comprises graphical patterns 87 for alignment and a graphical pattern 88 in form of alphanumerical characters for patient identification. </p><p id="p0108" num="0108"> Fig. 9a shows a top view of a further embodiment of a marker 90 according to the present invention, Fig. 9b shows a bottom view of the same. The marker 90 comprises a transparent carrier 91 and a combination of fluorescent pigments 92 that emit all needed wavelengths towards the tissue, in particular a first wavelength and a second wavelength. The marker 90 comprises reference areas 95 a and the first wavelength and reference areas 96a at the second wavelength. Furthermore, the marker 90 comprises optical filters 95b that constitute a first transmission area for transmitting light at a first wavelength and second filters 96b that constitute a second transmission area for transmitting light at the second wavelength. Even though the pigments 92 emit light at the first and the second wavelength, the filters only transmit light at one desired wavelength. Thereby, signals at different wavelengths are spatially separated for spatial decomposition and subsequent analysis. </p><p id="p0109" num="0109"> In this embodiment, the reference areas 95a, 96a and filters 95b, 96b are arranged in a check board design, however further arrangements are possible. In particular, if the signal at one wavelength is weaker than the other wavelength, a larger area can be used for the weaker wavelength to have a similar light intensity at both wavelengths. Event though the shown embodiments illustrate the use of two different wavelengths it is to be understood that additional wavelengths can be evaluated. If only a time- variant intensity is of interest, the evaluation of a single wavelength can be sufficient. </p><p id="p0110" num="0110"> While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or 
<!-- EPO <DP n="22"/>-->
 exemplary and not restrictive; the invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments can be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims. </p><p id="p0111" num="0111"> In the claims, the word "comprising" does not exclude other elements or steps, and the indefinite article "a" or "an" does not exclude a plurality. A single element or other unit may fulfill the functions of several items recited in the claims. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage. </p><p id="p0112" num="0112"> A computer program may be stored/distributed on a suitable medium, such as an optical storage medium or a solid-state medium supplied together with or as part of other hardware, but may also be distributed in other forms, such as via the Internet or other wired or wireless telecommunication systems. </p><p id="p0113" num="0113"> Any reference signs in the claims should not be construed as limiting the scope. 
</p></description><claims mxw-id="PCLM70077908" ref-ucid="WO-2014128172-A1" lang="EN" load-source="patent-office"><claim-statement><!-- EPO <DP n="23"/>-->CLAIMS: </claim-statement><claim id="clm-0001" num="1"><claim-text>1. A marker (10, 10', 20, 30, 40, 60, 70, 80, 90) for use in a system (1) for determining vital sign information (7) of a subject (100), the system (1) comprising a remote detection unit (2, 52) for detecting radiation emitted by the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), the marker comprising </claim-text><claim-text> a marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) for emitting light towards a skin (104) of the subject (100) for remotely determining vital sign information (7) from the reflected light, and </claim-text><claim-text> attachment means (23, 43, 73) for attaching the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) to the subject (100). </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. The marker according to claim 1, </claim-text><claim-text>wherein the marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) comprises fluorescent pigments and/or luminescent pigments for emitting light towards the skin (104) of the subject (100). </claim-text></claim><claim id="clm-0003" num="3"><claim-text>3. The marker according to claim 2, </claim-text><claim-text>wherein fluorescent pigments convert light at a first wavelength (62) to light at a second wavelength (68), and wherein said first wavelength (62) is a non-visible wavelength. </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. The marker according to claim 1, </claim-text><claim-text>comprising a first marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) for emitting light at a first wavelength (46, 68) and/or a second marker area (11, 11 ', 22, 35, 36 42, 48, 65, 72, 82, 92) for emitting light at a second wavelength (49, 64). </claim-text></claim><claim id="clm-0005" num="5"><claim-text>5. The marker according to claim 1, </claim-text><claim-text>comprising a transmission area (74b, 75b, 76b, 85b, 86b, 95b, 96b) for transmitting light. </claim-text></claim><claim id="clm-0006" num="6"><claim-text>6. The marker according to claim 5, 
<!-- EPO <DP n="24"/>-->
 comprising a first transmission area for transmitting light at a first wavelength (46, 68) and/or a second transmission area for transmitting light at a second wavelength (49, 64). </claim-text></claim><claim id="clm-0007" num="7"><claim-text>7. The marker according to claim 1, </claim-text><claim-text>comprising an opaque marker area (47). </claim-text></claim><claim id="clm-0008" num="8"><claim-text>8. The marker according to claim 1, </claim-text><claim-text>further comprising a reference area (74a, 75a, 76a, 85a, 86a, 95a, 96a) of predefined reflection characteristic. </claim-text></claim><claim id="clm-0009" num="9"><claim-text>9. The marker according to claims 1, </claim-text><claim-text>further comprising a graphical pattern (31, 32, 87, 88, 97). </claim-text></claim><claim id="clm-0010" num="10"><claim-text>10. The marker according to claim 1, comprising </claim-text><claim-text>- a carrier layer (21, 41, 71, 81, 91) for providing mechanical stability of the marker (10, 10', 20, 30, 40, 60, 70, 80, 90), </claim-text><claim-text> a light emission layer (22, 42, 72, 82, 92) comprising fluorescent and/or luminescent pigments for emitting light towards the skin (104) of the subject (100) and </claim-text><claim-text> an attachment layer (23, 43, 73) comprising an adhesive for attaching the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) to the subject (100). </claim-text></claim><claim id="clm-0011" num="11"><claim-text>11. An applicator for applying a marker (10, 10', 20, 30, 40, 60) according to claim 1 to a skin (104) of a subject (100). </claim-text></claim><claim id="clm-0012" num="12"><claim-text>12. A system (1) for determining vital sign information (7) of a subject (100) comprising </claim-text><claim-text> a marker (10, 10', 20, 30, 40, 60, 70, 80, 90) according to claim 1, a remote detection unit (2, 52) for detecting radiation emitted by the marker</claim-text><claim-text>(10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), and </claim-text><claim-text> an analysis unit (6) for determining the vital sign information (7) of the subject</claim-text><claim-text>(100) from the detected radiation reflected from the skin (104) of the subject (100). 
<!-- EPO <DP n="25"/>-->
</claim-text></claim><claim id="clm-0013" num="13"><claim-text>13. A device (13) for use with a marker (10, 10', 20, 30, 40, 60, 70, 80, 90) according to claim 1 comprising </claim-text><claim-text> a remote detection unit (2, 52) for detecting radiation emitted by the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), and </claim-text><claim-text> an analysis unit (6) for determining the vital sign information (7) of the subject (100) from the detected radiation reflected from the skin (104) of the subject (100). </claim-text></claim><claim id="clm-0014" num="14"><claim-text>14. A method for determining vital sign information (7) of a subject (100) comprising the steps of </claim-text><claim-text> applying a marker (10, 10', 20, 30, 40, 60, 70, 80, 90) according to claim 1 to the subject (100), </claim-text><claim-text> remotely detecting radiation emitted by the marker (10, 10', 20, 30, 40, 60, 70, 80, 90) towards a skin (104) of the subject (100) and reflected from the skin (104) of the subject (100), </claim-text><claim-text> determining the vital sign information (7) of the subject (100) from the detected radiation reflected from the skin (104) of the subject (100). 
</claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
